ClinicalTrials.Veeva

Menu

The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction

Mayo Clinic logo

Mayo Clinic

Status

Enrolling

Conditions

Prostate Adenocarcinoma

Treatments

Diagnostic Test: Ulrasound Vibroelastography (UVE)

Study type

Interventional

Funder types

Other

Identifiers

NCT05109208
21-001713
NCI-2024-00502 (Other Grant/Funding Number)

Details and patient eligibility

About

Researchers are trying to determine whether there is additional utility to using vibroelastography, a noninvasive ultrasound technique to evaluate for the presence of tissue fibrosis, in conjunction with standard penile duplex Doppler ultrasound to assess erectile function (recovery) after prostate cancer surgery.

Enrollment

10 estimated patients

Sex

Male

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria include:

  • Age > 40 years
  • Clinically localized prostate cancer (American Urological Association Grade Groups 1-2; cT1c or cT2a-b; PSA < 10) without clinic or imaging evidence of localized extra-prostatic or metastatic disease (i.e. AUA low and favorable intermediate risk prostate cancer)
  • International Index of Erectile Function (IIEF) of ≥ 21 points at baseline (no or mild erectile dysfunction)
  • Patient-expressed interest in consultation for sexual function (erectile function) preservation/ optimization
  • Planned bilateral nerves-paring prostatectomy

Exclusion criteria include:

  • Moderate or severe ED based in IIEF criteria (score < 21)
  • History of prior pelvic or penile surgery
  • Current or prior androgen deprivation therapy
  • Planned non-nerve sparing prostatectomy

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Ultrasound viscoelastography (UVE) in radical proctectomy recovery
Experimental group
Description:
Subjects undergoing radical prostatectomy for prostate cancer disease as standard of care will have a ultrasound vibroelastography performed before surgery, 3 months, 6 months and 9 months post-prostatectomy.
Treatment:
Diagnostic Test: Ulrasound Vibroelastography (UVE)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems